The World Health Organization (WHO) has released an updated Position Paper on Pneumococcal Conjugate Vaccine (PCV) vaccination, introducing new recommendations on dose-reduced schedules, including the 2-dose “1p+1” schedule (one primary dose plus one booster dose).
While the 1p+1 schedule is not yet included in current PCV product licenses, WHO notes that off-label use may be justified under specific national conditions and with expert recommendations — offering potential benefits in cost savings and reduction of injections.
This webinar will:
- Present the updated WHO recommendations on PCV vaccination.
- Discuss key considerations for countries exploring the adoption of the 1p+1 schedule.
- Provide insights relevant to national immunization programme decisions.
Target audience:
- WHO and UNICEF colleagues (regional and country levels)
- National immunization programme managers
- Immunization partners and technical agencies
Language:
The webinar will be conducted in English, with simultaneous interpretation in French.
When:
Wednesday, November 19th, 1pm-2.30pm CET
Registration: https://who.zoom.us/webinar/register/WN_0NQIwZmfRhK1OnPfMNQdtg#/registration
- Page :
- 1